A reverse binding motif that contributes to specific protease inhibition by antibodies.
A reverse binding motif that contributes to specific protease inhibition by antibodies.
复制标题
DOI:
10.1016/j.jmb.2011.11.036
复制
发表时间:
2012-01-27
影响因子:
5.6
通讯作者:
Craik, Charles S.
中科院分区:
文献类型:
--
作者:
Schneider, Eric L.;Lee, Melody S.;Baharuddin, Aida;Goetz, David H.;Farady, Christopher J.;Ward, Mick;Wang, Cheng-I;Craik, Charles S.
The type II transmembrane serine protease (TTSP) family consists of eighteen closely related serine proteases that are implicated in multiple functions. To identify selective, inhibitory antibodies against one particular TTSP, matriptase (MT-SP1), a phage display library with a natural repertoire of Fabs from human naïve B cells was created. Fab A11 was identified with a 720 picomolar inhibition constant and high specificity for matriptase over other trypsin-fold serine proteases. A Trichoderma reesei system expressed A11 with ~200 mg/L yield. The crystal structure of A11 in complex with matriptase has been determined and compared to the crystal structure of another antibody inhibitor (S4) in complex with matriptase. Previously discovered from a synthetic scFv library, S4 is also a highly selective and potent matriptase inhibitor. The crystal structures of the A11/matriptase and S4/matriptase complexes were solved to 2.1 Å and 1.5 Å respectively. Although these antibodies, discovered from separate libraries, interact differently with the protease surface loops for their specificity, the structures reveal a similar novel mechanism of protease inhibition. Through the insertion of the H3 variable loop in a reverse orientation at the substrate-binding pocket, these antibodies bury a large surface area for potent inhibition and avoid proteolytic inactivation. This discovery highlights the critical role the antibody scaffold plays in positioning loops to bind and inhibit protease function in a highly selective manner. Additionally, Fab A11 is a fully human antibody that specifically inhibits matriptase over other closely related proteases, suggesting this approach could be useful for clinical applications.
登录
查看更多内容
影响因子:
11.2
作者:
Darragh MR;Schneider EL;Lou J;Phojanakong PJ;Farady CJ;Marks JD;Hann BC;Craik CS
通讯作者:
Craik CS
影响因子:
4.8
作者:
de Haard, HJ;van Neer, N;Hoogenboom, HR
通讯作者:
Hoogenboom, HR
影响因子:
5.6
作者:
Farady, Christopher J.;Sun, Jeonghoon;Craik, Charles S.
通讯作者:
Craik, Charles S.
影响因子:
5.6
作者:
Dickinson, CD;Shobe, J;Ruf, W
通讯作者:
Ruf, W
影响因子:
20.3
作者:
Kilpatrick, Lynette M.;Harris, Roger L.;Ellis, Vincent
通讯作者:
Ellis, Vincent